A rare case of bevacizumab-related osteonecrosis of the jaw associated with dental implants

被引：0
作者：
Gustavo Maluf
Rogério Jardim Caldas
Eduardo Rodrigues Fregnani
Paulo Sérgio da Silva Santos
机构：
[1] Private Clinic,Department of Stomatology, Bauru Dental School
[2] USP–University of São Paulo,Department of Oral Medicine
[3] Hospital Sírio-Libanês,Department of Stomatology, Bauru Dental School
[4] USP–University of São Paulo,undefined
来源：
International Journal of Implant Dentistry | / 5卷
关键词：
Osteonecrosis; Jaw; Bevacizumab; Angiogenesis inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 85 条
  • [1] Watters AL(2011)Oral complications of targeted cancer therapies: a narrative literature review Oral Oncol 47 441-448
  • [2] Epstein JB(2007)Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory none small-cell lung cancer J Clin Oncol 25 4743-4750
  • [3] Agulnik M(2011)Osteonecrosis of the jaw: dental outcomes in metastatic breast cancer patients treated with bisphosphonates with/without bevacizumab Clin Breast Cancer 11 252-257
  • [4] Herbst RS(2008)Osteonecrosis of the jaw related to bevacizumab J Clin Oncol 26 4037-4038
  • [5] O’Neill VJ(1995)Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: a case report Int J Oral Maxillofac Implants 10 74-78
  • [6] Fehrenbacher L(2013)Osteopathology induced by bisphosphonates and dental implants: clinical observations Clin Oral Investig 17 167-175
  • [7] Ngamphaiboon N(2014)Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment Clin Oral Implants Res 25 632-640
  • [8] Frustino JL(2008)Bevacizumab-associated osteonecrosis of the jaw Ann Oncol 19 2091-2092
  • [9] Kossoff EB(2014)American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw-2014 update J Oral Maxillofac Surg 72 1938-1956
  • [10] Estilo CL(2017)Antiresorptive agent-related osteonecrosis of the jaw: position paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw. Japanese Allied Committee on Osteonecrosis of the Jaw J Bone Miner Metab 35 6-19
123456789